Pexelizumab Completed Phase 3 Trials for Cardio-Pulmonary Bypass / Coronary Artery Bypass Graft Surgery Patients Prevention

IndicationsStatusPurposePhase
CompletedPrevention3
clinicaltrials.gov IdentifierTitleDrugs
NCT00048308Effect of Pexelizumab on All-Cause Mortality and Myocardial Infarction in Patients Undergoing Coronary Artery Bypass Graft Surgery With Cardio-Pulmonary Bypass